ChemoCentryx, Inc.
CCXI
CCXI was delisted on the 19th of October, 2022.
108 hedge funds and large institutions have $298M invested in ChemoCentryx, Inc. in 2018 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 30 increasing their positions, 45 reducing their positions, and 10 closing their positions.
20% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 10
2% more funds holding
Funds holding: 106 → 108 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9% less call options, than puts
Call options by funds: $1.48M | Put options by funds: $1.63M
13% less capital invested
Capital invested by funds: $344M → $298M (-$45.2M)
33% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 45
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.79M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$3.16M |
| 3 |
SCM
Sio Capital Management
New York
|
+$1.78M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$1.37M |
| 5 |
Renaissance Technologies
New York
|
+$1.17M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
-$2.18M |
| 2 |
Millennium Management
New York
|
-$1.91M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
-$1.09M |
| 4 |
Two Sigma Investments
New York
|
-$932K |
| 5 |
BI
BVF Inc
San Francisco,
California
|
-$909K |
CCXI Hedge Fund Activity: Q4 2018 in Review
108 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q4 2018, worth a combined $298M — down 13% from $344M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new CCXI positions and 10 closed out — a net gain of 2 holders — while 30 added to existing stakes and 45 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $6.79M. The largest seller was Baker Bros. Advisors, cutting an estimated $2.18M.
- 108 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q4 2018, up from 106 in Q3 2018.
- Funds reported $298M of ChemoCentryx, Inc. stock for Q4 2018, down 13% quarter-over-quarter.
- 12 funds opened new ChemoCentryx, Inc. positions in Q4 2018 and 10 closed out, a net change of +2 holders.
- The largest ChemoCentryx, Inc. buyer in Q4 2018 was Fidelity Investments, an estimated $6.79M added.
- The largest ChemoCentryx, Inc. seller in Q4 2018 was Baker Bros. Advisors, an estimated $2.18M sold.
Based on aggregated 13F filings for Q4 2018.